Riskpilot← Back to searchSign inGet full accessInnoCon Medical ApS
APSActiveCVR 38635794Lyngvej 1Manufacture of medical and dental instruments and supplies · NACE 3250Est. 201713 employeeswww.innoconmedical.dk
Revenue 2024
DKK 6,1M
+18% vs 2023
EBITDA margin
-7.3%
+22% vs 2023
Equity ratio
78.6%
Financial strength
Net profit 2024
DKK 173K
+146% vs 2023
| Revenue | DKK 6,1M | +18% |
| EBITDA | DKK -450K | +22% |
| Net profit | DKK 173K | +146% |
| Total assets | DKK 57,9M | +23% |
| Equity | DKK 45,5M | +29% |
| Employees | 13 | — |
Legal name
InnoCon Medical ApS
CVR number
38635794
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
9. maj 2017
Share capital
DKK 202.698
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse
Company purpose
Selskabet formål er at drive udviklingsvirksomhed
Address
Lyngvej 1
Email
contact@innoconmedical.dk
Website
www.innoconmedical.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -108 | -333 | -319 | -487 | -420 | 4.331 | 5.226 | 6.141 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -5.117 | -5.805 | -6.591 |
| EBITDA | -108 | -333 | -319 | -487 | -420 | -786 | -579 | -450 |
| Depreciation & amort. | -0 | -1 | -7 | -21 | -24 | -21 | -21 | -21 |
| EBIT | -108 | -335 | -326 | -508 | -443 | -807 | -600 | -471 |
| Net financials | -21 | -7 | -11 | -21 | -150 | -147 | -129 | -111 |
| Profit before tax | -129 | -342 | -337 | -529 | -594 | -953 | -729 | -582 |
| Tax | -25 | -88 | -94 | -563 | -704 | -775 | -350 | -755 |
| Net profit | -104 | -254 | -243 | 34 | 110 | -178 | -379 | 173 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1.819 | 13.242 | 14.225 | 20.275 | 28.301 | 35.123 | 46.957 | 57.864 |
| Equity | -54 | 6.291 | 6.048 | 16.082 | 20.830 | 25.290 | 35.282 | 45.483 |
| Long-term debt | 0 | 5.200 | 129 | 373 | 2.618 | 3.549 | 2.836 | 2.161 |
| Short-term debt | 1.736 | 881 | 6.033 | 876 | 702 | 1.022 | 1.535 | 1.515 |
| Total debt | 1.736 | 6.081 | 6.161 | 1.249 | 3.320 | 4.571 | 4.371 | 3.676 |
EBITDA margin
-7.3%
This company
15.8%
Market median
-146% vs market
20172024
Equity ratio
78.6%
This company
38.2%
Market median
+106% vs market
20172024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20172024
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20172024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20172024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-05-09 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JN Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Blokhus Invest ApS | Company | 20.0% | 20.0% | 2026 |
Shasta Holding ApS | Company | 15.0% | 15.0% | 2020 |
NORLAU ApS | Company | 10.0% | 10.0% | 2021 |
Familien Jespersen Invest ApS | Company | 10.0% | 10.0% | 2026 |
Familien Helt Invest ApS | Company | 10.0% | 10.0% | 2026 |
Familien Bekker ApS | Company | 5.0% | 5.0% | 2026 |
JLJ BUSINESS DEVELOPMENT ApS | Company | 5.0% | 5.0% | 2018 |
Moelholm C&C A/S | Company | 5.0% | 5.0% | 2020 |
BEKKER INVEST ApS | Company | 5.0% | 5.0% | 2020 |
T. HELT HOLDING ApS | Company | 5.0% | 5.0% | 2018 |
J U HOLDING ApS | Company | 5.0% | 5.0% | 2018 |
J.U. HOLDING ApS | Company | 5.0% | 5.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORLAU ApS
InnoCon Medical ApS Board members of InnoCon Medical ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Nielsen | Management | 0 companies |
| Ulrik Jespersen | Board of Directors | 0 companies |
| Axel Nørskov Laursen | Board of Directors | 0 companies |
| Frank Blömer | Board of Directors | 0 companies |
| Jens Lübeck Johansen | Board of Directors | 0 companies |
| Axel Nørskov Laursen | Board of Directors | 0 companies |
| Jesper Fjeldsø Jensen | Board of Directors | 0 companies |
| Ulrik Spork | Chairman | 0 companies |